The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 6, 1999, Pages 580-586

  Gustafsson, A ^a,b   Berstad, A ^a,b   Lund Tonnesen S ^a,b   Midtvedt, T ^a,b   Norin, E ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

aspartylglycine; Antibiotic associated diarrhoea; Coprostanol; Faecal enema; Microflora; Mucin; Tryptic activity; Urobilinogen

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFALOTIN; CEFUROXIME; CHOLESTEROL; CIPROFLOXACIN; CLINDAMYCIN; COPROSTEROL; ENEMA; METRONIDAZOLE; MUCIN; NETILMICIN; PENICILLIN G; PIVAMPICILLIN; SPIRAMYCIN; TETRACYCLINE; TRYPSIN; UROBILINOGEN; VANCOMYCIN;

ADULT; AGED; ARTICLE; BILE ACID SYNTHESIS; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; DIARRHEA; DIETARY INTAKE; DRUG EFFECT; ELECTROPHORESIS; ENZYME ACTIVITY; FECES MICROFLORA; FEMALE; GAS CHROMATOGRAPHY; HUMAN; INTESTINE FLORA; MALE; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; BIOLOGICAL THERAPY; CHOLESTANOL; CHOLESTEROL; DIARRHEA; DIPEPTIDES; ENEMA; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCINS; TRYPSIN; UROBILINOGEN;

EID: 0032788003     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750026038     Document Type: Article

References (32)

1. 1. Kelly CP, Pothoulakis C, LaMont JT. Clostridium difficile colitis. N Engl J Med 1994;330:257-62.
2. 2. Nord CE, Edlund C. Ecological effects of antimicrobial agents on the human intestinal microflora. Microb Ecol Health Dis 1991;4:193-207.
3. 3. Bartlett JG, Antibiotic-associated diarrhoea. Clin Infect Dis 1992;15:573-81.
4. 4. Midtvedt T, Carlstedt-Duke B, Høverstad T, Lingaas E, Norin KE, Saxerholt H, et al. Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects. Eur J Clin Invest 1986;16:11-7.
5. 5. Steinbakk M, Lingaas E, Carlstedt-Duke B, Høverstad T, Midtvedt A-C, Norin KE, et al. Faecal concentration of ten antibiotics and influence on some microflora-associated characteristics (MACs). Microb Ecol Health Dis 1992;5:269-76.
6. 6. Hove H, Tvede M, Mortensen PB, Antibiotic-associated diarrhoea, Cloxtridium difficile, and short-chain fatty acids. Scand J Gastroenterol 1996;31:688-93.
7. 7. Midtvedt T. Microflora-associated characteristics (MACs) and germfree animal characteristics (GACs) in man and animals. Microecol Ther 1985;15:295-302.
8. 8. Midtvedt T. Influence of antibiotics on biochemical intestinal microflora-associated characteristics in man and animals. In: Gillissen G, Opferkuch W, Peters G, Pulverer G, editors. The influence of antibiotics on the host-parasite relationship. III. Berlin: Springer-Verlag; 1989. p. 209-15.
9. 9. Andréasson K, Norin KE, Midtvedt T. Influence of ampicillin, clindamycin or metronidazol upon the 7α-dehydroxylation of bile acids in the human intestine. Curr Microbiol 1988;6:329-31.
10. 10. Gustafsson A, Lund-Tønnesen S, Berstad A, Midtvedt T, Norin E. Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 1998;33:721-7.
11. 11. Midtvedt AC, Carlstedt-Duke B, Norin KE, Saxerholt H, Midtvedt T. Development of five metabolic activities associated with the intestinal microflora of healthy infants. J Ped Gastroenterol Nutr 1988;7:559-67.
12. 12. Midtvedt T, Carlstedt-Duke B, Høverstad T, Midtvedt AC, Norin KE, Saxerholt H. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. Appl Environ Microb 1987;53:2866-71.
13. 13. Collinder E, Lindholm A, Midtvedt T, Norin E. Intestinal biochemical microbial functions in the horse. Equine Vet J. In press, 1999.
14. 14. Midtvedt T, Lingaas E, Carlstedt-Duke B, Høverstad T, Midlvedt A-C, Saxerholt H, et al. Intestinal microbial conversion of cholesterol to coprostanol in man. APMIS 1990;98:839-44.
15. 15. Lichtenstien AH. Intestinal cholesterol metabolism. Ann Med 1990:22:49-52.
16. 16. Midtvedt AC, Midtvedt T. Conversion of cholesterol to coprostanol by the intestinal microflora during the first two years of human life. J Ped Gastroenterol Nutr 1993;17:161-8.
17. 17. Freier TA, Beitz DC, Li L, Hartman PA. Characterization of Eubacterium coprostanoligenes sp.nov., a cholesterol-reducing anaerobe. Int J Syst Bacteriol 1994;44:137-42.
18. 18. Ren D, Li L, Schwabacher AW, Young JW, Beitz DC. Mechanism of cholesterol reduction to coprostanol by Eubacterium coprostanoligenes ATCC 51222. Steroids 1996;61:33-40.
19. 19. Sadzikowski MR, Sperry JF, Wilkins TD. Cholesterol-reducing bacterium from human feces. Appl Environ Microbiol 1997;34: 355-62.
20. 20. Saxerholt H, Carlstedt-Duke B, Høverstad T, Lingaas E, Norin KE, Steinbakk M, et al. Influence of antibiotics on the faecal excretion of bile pigments in healthy subjects. Scand J Gastroenterol 1986;21:991-6.
21. 21. Gadelle D, Raibaud P, Sacquet E. β-Glucuronidase activities of intestinal bacteria determined both in vitro and in vivo in gnotobiotic rats. Appl Environ Microbiol 1985;49:682-5.
22. 22. Cole CB, Fuller R, Mallet AK, Rowland IR. The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds. J Appl Bact 1985;59:549-63.
23. 23. Midtvedt T, Gustafsson BE. Microbial conversion of bilirubin to urobilins in vitro and in vivo. Acta Pathol Microbiol Immunol Scand [B] 1981;89:57-60.
24. 24. Gustafsson A, Norin E, Midtvedt T. Establishment of some microflora-associated characteristics in ex-germfree rats and the developmental pattern. Scand J Lab Animal Sci 1996;23:109-16.
25. 25. Ramare F, Hautefort I, Verhe F, Raibaud P, Iovanna J. Inactivation of tryptic activity by a human-derived strain of Bacteroides distasonis in the large intestines of gnotobiotic rats and mice. Appl Environ Microbiol 1996;62:1434-6.
26. 26. Carlstedt-Duke B, Midtvedt T, Nord CE, Gustafsson BE. Isolation and characterization of a mucin-degrading strain of Peptostreptococcus from rat intestinal tract. Acta Pathol Microbiol Immunol Scand [B] 1986;94:293-300.
27. 27. Hoskins LC. Bacterial glycosidases and degradation of glycoconjugates in the human gut. In: Wadström T, Mäkelä PH, Svennerholm A-M, Wolf-Watz H, editors. Molecular pathogenesis of gastrointestinal infections. New York: Plenum Press; 1991. p. 37-47.
28. 28. Carlstedt-Duke B, Høverstad T, Lingaas E, Norin KE, Saxerholt H, Steinbakk M, et al. Influence of antibiotics on intestinal mucin in healthy subjects. Eur J Clin Microbiol 1986;5:634-8.
29. 29. Bowden TA, Mansberger A, Lykins L, Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg 1981;47:178-83.
30. 30. Schwan A, Sjölin S, Trottestam U, Aronsson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces. Scand J Infect Dis 1984;16:211-5.
31. 31. Schwan A, Sjölin S, Trottestam U, Aronson B. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet 1983;10:845.
32. 32. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989;1: 1156-60.